<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>Revista de Științe ale Sănătății din Moldova</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/531</link>
<description>Moldovan Journal of Health Sciences</description>
<pubDate>Mon, 28 Sep 2026 06:12:52 GMT</pubDate>
<dc:date>2026-09-28T06:12:52Z</dc:date>
<item>
<title>Predictors of community-acquired pneumonia severity in patients with chronic heart failure</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/33679</link>
<description>Predictors of community-acquired pneumonia severity in patients with chronic heart failure
Cașcaval, Virginia; Dumitraș, Tatiana; Fetco-Mereuță, Diana; Grib, Livi; Matcovschi, Sergiu; Talmaci, Cornelia; Caproș, Natalia; Bivol, Elena
Introduction. Community-acquired pneumonia (CAP) remains a major cause of morbidity and mortality, particularly in&#13;
patients with chronic heart failure (CHF), who are at increased risk of adverse outcomes. Identifying reliable predictors&#13;
of disease severity in this population is essential for timely risk stratification and optimization of therapeutic strategies.&#13;
Aim of the study. Assessment of clinical and disease-course characteristics, oxidative stress, and predictors of CAP severity&#13;
in patients with CHF.&#13;
Materials and methods. A total of 210 patients were enrolled in the study and divided into two groups: group 1 (n =&#13;
105) – patients with community-acquired pneumonia associated with chronic heart failure and group 2 (n = 105) – patients&#13;
with community-acquired pneumonia without chronic heart failure. The research was conducted based on clinical&#13;
examination of patients, daily monitoring of the inflammatory process, assessment of comorbidities, and paraclinical investigations.&#13;
Statistical analysis of the collected data was performed using a wide range of methods, including descriptive&#13;
statistics, correlational analysis, and regression models.&#13;
Results. The age of patients in the study group ranged from 50 to 92 years, with a mean of 70.6 ± 8.89 years (95% CI&#13;
[68.8–72.3]), (F = 18.109; p = 0.205). In Group 1, the proportion of women was 57 (54.3%; 95% CI [44.8-64.1]), and that&#13;
of men was 48 (45.7%; 95% CI [35.9-55.2]). In Group 2, the proportion of men was higher than that of women: 54 (51.4%;&#13;
95% CI [42.3-61.0]) men and 51 (48.6%; 95% CI [39.0-57.7]) women, respectively (χ2 = 0.686; df = 1; p = 0.407). Ischemia-&#13;
modified albumin values were higher in patients in Group 1 compared to Group 2: 236.60 ± 57.23 μM/L and 229.77 ±&#13;
64.35 μM/L, respectively, (F = 0.660; p = 0.045). The IMA threshold value of 218.98 μM/L was determined for patients with&#13;
CHF and severe CAP. The mean NT-proBNP values in Group 1 patients were 1371.88 ± 498.91 pg/ml, compared to Group 2:&#13;
58.19 ± 48.22 pg/ml, (F = 721.54; p &lt; 0.0001). The NT-proBNP threshold value of 1665.73 pg/ml was identified for severe&#13;
CAP in CHF patients. A method which allows early detection in 87.0% of cases of patients with CHF at high risk of severe&#13;
community-acquired pneumonia was developed.&#13;
Conclusions. Our hypothesis that community-acquired pneumonia in patients with chronic heart failure is more frequently&#13;
associated with a severe clinical course was confirmed. The proposed NT-proBNP and ischemia-modified albumin threshold&#13;
values, together with our risk estimation formula, may improve early therapeutic intervention to prevent severe complications.
</description>
<pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://repository.usmf.md:80/xmlui/handle/20.500.12710/33679</guid>
<dc:date>2026-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Non-immune fetal hydrops and intestinal obstruction: rare manifestations of congenital syphilis</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/33662</link>
<description>Non-immune fetal hydrops and intestinal obstruction: rare manifestations of congenital syphilis
Neagu, Anastasia; Crivceanscaia, Larisa
Introduction. Fetal hydrops is defined as the pathological accumulation of extracellular fluid in at least two fetal anatomical compartments, including skin edema (&gt; 5 mm thickness), pericardial effusion, pleural effusion, and ascites. Non-immune fetal hydrops (NIHF) accounts for over 90% of all fetal hydrops cases and has a heterogeneous etiology. Congenital&#13;
infections contribute to approximately 6–7% of NIHF cases and are associated with a severe neonatal prognosis.&#13;
Case presentation. A preterm newborn was delivered from a pregnancy complicated by untreated maternal primary&#13;
syphilis. The fetus had been diagnosed antenatally with NIHF, heart failure, and massive ascites. Postnatally, the infant&#13;
required early ascitic drainage and subsequently underwent surgery for congenital intestinal obstruction in the context&#13;
of ileal stenosis. Neonatal serological testing revealed a positive rapid plasma reagin (RPR) and a reactive Treponema pallidum Hemagglutination Assay (TPHA). Management of congenital syphilis was carried out according to the standardized&#13;
national clinical protocol. The collected data were compared with those reported in the existing literature to assess clinical&#13;
significance.&#13;
Results. The neonate showed a favorable clinical evolution following multidisciplinary management, including intensive&#13;
care support, anti-infective therapy, and surgical correction of the intestinal obstruction. Progressive improvement allowed successful postoperative recovery and discharge in satisfactory condition.&#13;
Conclusions. Early identification of the infectious etiology of fetal hydrops is essential for the implementation of appropriate management and the improvement of neonatal outcomes. Close collaboration between maternal–fetal medicine,&#13;
neonatology, and pediatric surgery is crucial in managing such complex cases.
</description>
<pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://repository.usmf.md:80/xmlui/handle/20.500.12710/33662</guid>
<dc:date>2026-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Healthcare-associated bloodstream infections in children: epidemiology, risk factors and prevention strategies</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/33661</link>
<description>Healthcare-associated bloodstream infections in children: epidemiology, risk factors and prevention strategies
Marga, Irina
Introduction. Health care-associated bloodstream infections represent a major public health concern, significantly impacting morbidity, mortality, and the overall cost of pediatric medical care.&#13;
Materials and methods. A literature review was conducted based on systematic searches in PubMed, SCOPUS, and Web&#13;
of Science, following PRISMA guidelines.&#13;
Results. The incidence of healthcare-associated bloodstream infections ranges from 2 to 25 cases per 1,000 central venous&#13;
catheter days, with higher rates reported in pediatric and neonatal intensive care units, where patients are frequently&#13;
exposed to risk factors such as central venous catheter use, mechanical ventilation, and immunosuppression. Pediatric&#13;
patients with health care-associated bloodstream infections experience significantly longer hospital stays compared to&#13;
those without infection (25 vs. 7 days, P &lt; 0.0001). In pediatric intensive care units, the average length of hospital stay due&#13;
to these infections varies between 11.40 and 21.10 days, while in neonatal intensive care units, it ranges from 4 to 27.80&#13;
days. Mortality associated with these infections among children varies between 15% and 50%, depending on the severity&#13;
of infection and underlying comorbidities. Additionally, health care-associated bloodstream infections lead to increased&#13;
use of medical resources and generate substantial additional costs for the healthcare system-costs that are, in fact, largely&#13;
preventable.&#13;
Conclusions. Evidence-based strategies, such as strict hand hygiene and standardized protocols for medical device use,&#13;
can significantly reduce the incidence of these infections.
</description>
<pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://repository.usmf.md:80/xmlui/handle/20.500.12710/33661</guid>
<dc:date>2026-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Tick-borne mix infection diagnosis, challenges, and current practices</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/33657</link>
<description>Tick-borne mix infection diagnosis, challenges, and current practices
Sofronie, Olga; Bălan, Greta
Introduction. Tick-borne infections (TBIs) are increasingly recognized as a public health concern in North America and&#13;
Europe, with Lyme disease being the most notable. The Centers for Disease Control and Prevention (CDC) acknowledges&#13;
that official statistics likely underestimate the true incidence of TBIs due to diagnostic challenges and underreporting.&#13;
Co-infections, where multiple pathogens are transmitted through a single tick bite or multiple bites, complicate diagnosis&#13;
and treatment, leading to more severe symptoms and longer illness durations. Studies indicate a significant percentage of&#13;
Lyme disease patients also have co-infections, with babesiosis being a common co-infection.&#13;
Materials and methods. A comprehensive narrative literature review was conducted using PubMed and Scopus, resulting&#13;
in 52 manuscripts. Additional reports from the CDC and European Centre for Disease Prevention and Control (ECDC), as&#13;
well as relevant academic books, were included to meet the study’s objectives. The Elicit platform was utilized to enhance&#13;
reference identification and information synthesis.&#13;
Results. The paper provides an overview of tick-borne co-infections, emphasizing the diagnostic challenges posed by overlapping and nonspecific symptoms. It discusses various diseases, including Lyme disease, babesiosis, anaplasmosis, ehrlichiosis, Rocky Mountain spotted fever, and tick-borne encephalitis, detailing their causative organisms, vectors, clinical&#13;
features, and common co-infections. The review critically examines diagnostic methods such as serological tests, molecular&#13;
tests, and blood smears, highlighting issues like the „window period” false negatives/positives, and differentiating active&#13;
from past infections. It also explores emerging technologies and biomarkers, including multiplex assays and next-generation sequencing, which enhance detection capabilities but face challenges in data analysis and standardization.&#13;
Conclusions. Accurate diagnosis is crucial to manage these infections effectively, particularly in vulnerable populations.&#13;
The rise in co-infections and inadequate testing presents a significant public health challenge, necessitating improved surveillance and diagnostic approaches.
</description>
<pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://repository.usmf.md:80/xmlui/handle/20.500.12710/33657</guid>
<dc:date>2026-01-01T00:00:00Z</dc:date>
</item>
</channel>
</rss>
